Episode 2: An in-depth look at the results from ASCENDE-RT and RTOG 0232

Welcome to the Isoray Prostate Cancer Connect Podcast! In each episode of the new podcast series, Dr. John Sylvester and featured guests will talk in-depth about the current status and advancements in brachytherapy for prostate cancer treatment. In this episode, Dr....

Episode 1: What’s needed when we should be doing more quality brachytherapy procedures, not fewer?

Welcome to the Isoray’s Prostate Cancer Connect Podcast! Each episode of the new podcast series, Dr. John Sylvester and featured guests will be talking in-depth about the current status and advancements in brachytherapy for prostate cancer treatment. Dr. John...

Isoray Announces Record First Quarter Fiscal 2020 Financial Results

Record Revenue and Gross Profit Revenue Increased 48% Year-Over-Year  RICHLAND, WASHINGTON – November 12, 2019 – Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the...

Isoray To Announce First Quarter Fiscal 2020 Financial Results on November 12, 2019

Conference Call is Tuesday, November 12, 2019 at 4:30 p.m. ET/1:30 p.m. PT RICHLAND, WASHINGTON – October  31, 2019 – Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout...

Isoray Will Have Prominent Role at American Brachytherapy Society’s Annual Prostate Brachytherapy Workshop

RICHLAND, WASHINGTON – October 29, 2019 – Isoray, Inc. (NYSE AMERICAN: ISR)  announced today that it will demonstrate its latest products at the American Brachytherapy Society’s (ABS) annual prostate brachytherapy workshop. The workshop is scheduled to take place...